Min-suk K. Yang

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 87 publications

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Long-Acting Muscarinic Antagonist as an Alternative to Inhaled Corticosteroids in Type 2-Low Mild Asthma: A Randomized Crossover Non-inferiority Trial.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 25, 2026

Expiratory pulmonary vascular retention on computed tomography as a marker of asthma severity.

Expiratory pulmonary vascular retention on computed tomography as a marker of asthma severity.

Journal: The Journal of allergy and clinical immunology

Published: February 06, 2026

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.

Circulating 1-Methylnicotinamide Predicts Dupilumab Response in Adult Asthma: A Prediction Model.

Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology

Published: November 02, 2025

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma.

Journal: Allergy

Published: October 28, 2025

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Reply to "Optimizing FeNO and blood eosinophil stratification in eosinophilic asthma study: Adjusting for smoking history and blood sampling time".

Journal: The journal of allergy and clinical immunology. In practice

Published: August 20, 2025

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Siglec-8 as a Biomarker for Predicting Anti-IL-5 Response in Severe Asthma.

Journal: Allergy, asthma & immunology research

Published: April 05, 2025

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings From the Precision Medicine Intervention in Severe Asthma Study.

Journal: The journal of allergy and clinical immunology. In practice

Published: February 04, 2025

Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction.

Clinical characteristics and risk factors for escalation to anaphylaxis from non-severe drug hypersensitivity reaction.

Journal: Clinical and translational allergy

Published: November 04, 2024

Pilot study: Unveiling the impact of bisphenol A and phthalate exposure on women with asthma.

Pilot study: Unveiling the impact of bisphenol A and phthalate exposure on women with asthma.

Journal: Medicine

Published: September 27, 2024

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Biomarkers of type 2 inflammation as predictors of response to biologics for severe eosinophilic asthma.

Journal: ERJ open research

Published: September 25, 2024

Effects of indoor environments and outdoor air pollutants in residential areas on acute exacerbation in patients with severe asthma.

Effects of indoor environments and outdoor air pollutants in residential areas on acute exacerbation in patients with severe asthma.

Journal: International journal of environmental health research

Published: August 13, 2024

Therapeutic Effectiveness of SNOT 22-Based Interdose Interval Adjustment of Dupilumab for Chronic Rhinosinusitis With Nasal Polyps.

Therapeutic Effectiveness of SNOT 22-Based Interdose Interval Adjustment of Dupilumab for Chronic Rhinosinusitis With Nasal Polyps.

Journal: Clinical and experimental otorhinolaryngology

Published: August 13, 2024

Showing 1-12 of 87

Last Updated: 09/26/2026